Singh Dave

Publicaţii peste hotare - 2, Descărcări - 1, Vizualizări - 332

2023 - 1

Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial

Belperio John A. , Nguyen Tuan , Lombardi David A. , Boguş Maxim , Moskalenko Valentyn , Singh Dave , Haumann Brett , Bourdet David L. , Kaufman Elad , Pfeifer Nathan D. , Thompson Corbin G. , Woo Jacky , Moran Edmund J. , Saggar Rajeev

BMJ Open Respiratory Research

Nr. / 2023 / ISSN 2052-4439

Disponibil online 15 August, 2023. Descarcări-1. Vizualizări-144

-----------------------------------------------------------------------------------------------------------------------------------

2021 - 1

A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19

Singh Dave , Boguş Maxim , Moskalenko Valentyn , Noi Autori

European Respiratory Journal

Nr. / 2021 / ISSN 0903-1936 / ISSNe 1399-3003

Disponibil online 19 July, 2023. Descarcări-0. Vizualizări-188

-----------------------------------------------------------------------------------------------------------------------------------

1020304050100150200500

1 - 2 of 2